This randomized controlled trial evaluated the effects of Melanotan II, a melanocortin receptor agonist, on penile erection and sexual desire in men with psychogenic and organic erectile dysfunction (ED). Among 20 participants, 85% experienced spontaneous penile erections without sexual stimulation, and 68% reported increased sexual desire after Melanotan II administration,
